Go to Top
[maxbutton id="1"]

Start-Up

New Mexico Startup Agilvax Moves to Phase II of SBIR Grant

New Mexico biotech company Agilvax, Inc., headquartered in Albuquerque, with offices in El Paso and at the Johnson & Johnson Innovation labs at Texas Medical Center (JLABS @ TMC) in Houston, is commercializing a virus-like particle (VLP) technology platform, developed by researchers Dr. David Peabody and Dr. Bryce Chackerian from the University of New Mexico, for targeted cancer immunotherapies and vaccines.  The company’s AX09 cancer immunotherapy is being developed to …Read More

New Mexico Startup Receives $1.2 Million Grant from DOE and Follow-on State Funding for Its Solar Cell Technology

Local startup Osazda Energy, commercialization solar cell technology jointly developed at the University of New Mexico and the Air Force Research Laboratory New Mexico by UNM Regents’ Professor Sang M. Han and his team, has received great news.  Osazda, a New Mexico Angels Start-Up Factory II-funded company, is developing innovative new materials that improve the efficiency and life of solar cells and panels for the photovoltaic market.   Solar cells today …Read More

Philadelphia Investor Puts Albuquerque in Top Ten for Entrepreneurs

Philadelphia entrepreneur and investor Bob Moore is an expert in data analytics.  The co-founder of RJ Metrics and the recently launched Crossbeam, a B2B software company that uses data analytics to help companies find partnerships, recently conducted a study of 100 cities in the US with the highest spending power for startups.  Albuquerque made the top ten list at number 5.  To read more, see Collin Krabbe’s January 23, 2019 …Read More

Albuquerque Biotech Company Agilvax Welcomes Prestigious Scientist to Board

Local biotech company Agilvax, Inc., headquartered in Albuquerque, is commercializing a virus-like particle (VLP) technology platform, developed by researchers Dr. David Peabody and Dr. Bryce Chackerian from the University of New Mexico, for targeted cancer immunotherapies and vaccines.  The company’s AX09 cancer immunotherapy is being developed for one of the hardest to treat cancers—triple negative breast cancer.  The company recently appointed Dr. David T. Hung, founder and former CEO of …Read More

Lens Launch Party Tests New Device

Local startup Lens unveiled its lumen device  at a December 6th launch party for the company at the Lobo Rainforest Building.   Lens is developing a technology to give online users control over their own data in an innovative peer-to-peer online communications program that circumvents current social media platforms to give users cloud-free online privacy and security.  See Collin Krabbe’s December 7, 2018 article, “Former Salesforce exec debuts new technology behind …Read More

Dr. Yun Li Joins VIC Technology Venture Development™ as Managing Director – New Mexico Branch

Executive with Extensive Startup Business Experience Leads VIC’s New Mexico Expansion FAYETTEVILLE, AR – December 19, 2018 – VIC Technology Venture Development™ (VIC) is pleased to welcome Dr. Yun Li as Managing Director – New Mexico Branch.  Dr. Li is also serving as interim CEO of VIC portfolio company Nob Hill Therapeutics, Inc. Her multifaceted professional career spans from R&D and global program management in Fortune 500 companies to technology …Read More

ABQ startup brings blazing fast internet to local college

Albuquerque startup OptiPulse Inc. will soon  be testing its laser chips for wireless networking at Central New Mexico Community College’s (CNM) main campus.  The company has developed 10 gigabytes-per-second speeds using its proprietary laser chips  that will save energy and lower the cost of transmitting data.   OptiPulse has received funding from the STC Co-Investment Fund to develop the technology.  To read more about the upcoming pilot project at CNM, see …Read More

Albuquerque Biotech Company Agilvax Appoints Executive Chairman to Its Board

Local biotech company Agilvax, Inc., headquartered in Albuquerque, is commercializing a virus-like particle (VLP) technology platform, developed by researchers Dr. David Peabody and Dr. Bryce Chackerian from the University of New Mexico, for targeted cancer immunotherapies and vaccines.  The company’s AX09 cancer immunotherapy is being developed for one of the hardest to treat cancers—triple negative breast cancer.  See the company’s latest press release, reprinted below. Agilvax Appoints Joseph Patti, Ph.D. …Read More

Albuquerque’s Growing Startup Ecosystem Catches National Attention

A just released report by Startup Genome, a data and analysis organization devoted to startup ecosystem research, profiled Albuquerque, along with five other mid-sized US cities (Fresno, CA, Hartford, CT, New Orleans, LA, Reno, NV, and Springfield, MA) for their emerging startup ecosystems.  The study, “How Early-Stage Ecosystems Are Developing in the United States,” was funded by the Kauffman Foundation, and examines how these mid-tier cities (with smaller populations and …Read More

Local Startup Lens to Sell First Product

Local startup Lens will soon sell its first product at a December 6th launch party for the company at the Lobo Rainforest Building.   Lens is developing a technology to give online users control over their own data in an innovative peer-to-peer online communications program that circumvents current social media platforms to give users cloud-free online privacy and security.  The device, called a “Lumen,” is completely independent of social media “platform …Read More